SYNGAP1 and neurodevelopmental disorder: Since aberrations in the SYNGAP1 gene have been linked to neurodevelopmental disorders [21], we discuss the possibility of SYNGAP1 being a key mediator of the association between adolescent cannabis use and adverse neuropsychiatric outcomes [22].